Pawcatuck, CT, United States of America

Chris Limberakis

USPTO Granted Patents = 15 

 

 

Average Co-Inventor Count = 12.5

ph-index = 6

Forward Citations = 82(Granted Patents)


Location History:

  • Saline, MI (US) (2007 - 2009)
  • Pawatuck, CT (US) (2016)
  • Pawcatuck, CT (US) (2019 - 2024)

Company Filing History:


Years Active: 2007-2025

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):

Title: Chris Limberakis: Innovator in Pawcatuck

Introduction: Chris Limberakis, a prolific inventor based in Pawcatuck, CT, has made significant contributions to the field of pharmaceuticals with a total of 12 patents to his name.

Latest Patents: Limberakis' latest patents include groundbreaking work on GLP-1 receptor agonists and their uses. These patents focus on the development of 6-carboxylic acids of benzimidazoles and various aza-benzimidazoles as GLP-1R agonists, highlighting his innovative approach to drug development.

Career Highlights: With a rich professional background, Limberakis has made significant strides at renowned pharmaceutical companies such as Pfizer Corporation and Warner-Lambert Company. His tenure at these esteemed organizations has been marked by a dedication to innovation and a relentless pursuit of excellence in the pharmaceutical industry.

Collaborations: Throughout his career, Limberakis has collaborated with industry experts such as Gary Erik Aspnes and Scott William Bagley. These partnerships have not only enriched his work but have also led to the development of cutting-edge pharmaceutical solutions that have the potential to impact the lives of many.

Conclusion: Chris Limberakis stands as a shining example of an inventor who has carved a niche for himself in the competitive world of pharmaceutical innovations. His dedication, expertise, and collaborative spirit continue to drive advancements in the field, making him a respected figure in the realm of inventors and innovators.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…